Detroit, MINCT05023772Now EnrollingIRB Ready

Neoplasm Metastasis Clinical Trial in Detroit, MI

Access cutting-edge neoplasm metastasis treatment through this clinical trial at a research site in Detroit. Study-provided care at no cost to qualified participants.

Sponsored by Henry Ford Health System

Quick Self-Assessment

See if you qualify for this Detroit location

Preparing your pre-screening questions…

Expert Care in Detroit

Access neoplasm metastasis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related neoplasm metastasis treatment provided free

Apply for This Detroit Location

Check if you qualify for this neoplasm metastasis clinical trial in Detroit, MI

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Detroit

    Convenient for MI residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Detroit site if eligible
  4. 4Begin participation

About This Neoplasm Metastasis Study in Detroit

The purpose of this research is to combine two complementary modes of treatment, spinal interstitial laser ablation and stereotactic spine radiosurgery (SSRS) for the treatment for spinal tumors near the spinal cord with an objective to improve tumor control, improve pain control, preserve function, and improve quality of life. We will also assess how effective these combined modes of treatment are in patients with spinal metastasis with an epidural component.

Sponsor: Henry Ford Health System

Who Can Participate

Inclusion Criteria

Age \> 18 years old. (The indication for this technique is controversial in skeletally immature patients.)
Histologic diagnosis of solid malignant tumor (not one of the more radiosensitive histologic subtypes, see

Exclusion Criteria

), including but not limited to non-small cell lung cancer, breast, prostate, renal cell, melanoma, gastrointestinal, sarcoma, thyroid, head and neck primary, and unknown primary tumors.
Quantification of the degree of epidural spinal cord compression as grade 1C, 2, or 3 by MRI, with and without contrast sequences. Axial T2 sequence is encouraged but not required.
The vertebral body site to be treated must be located from T2 to L1
No more than 3 contiguous or dis-contiguous vertebral levels involved with metastasis in the spine to be irradiated in a single session or 3 sessions.
Motor strength ≥4 out of 5 in extremity or extremities affected by the level of the spinal cord compression (see section 4 for grading method).
ECOG performance status \<2 or Karnofsky performance status (KPS) \>50
Life expectancy \>3 months.
Inoperable disease because of patient refusal, neurosurgical evaluation, or any other medical reasons.
Women of child-bearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) before study entry and for the duration of study participation. Should a woman become pregnant or suspect she is pregnant while she or her partner is participating in this study, she should inform her treating physician immediately.
Prior conventional radiation to the same site is allowed as long as there is a greater than 3 months interval.
Signed informed consent. Exclusion Criteria:
Requires open spinal procedure or a percutaneous procedure without the use of image guidance.
Primary tumors of radiosensitive histology (lymphoma, multiple myeloma, small cell carcinoma, germ cell tumors), as conventional radiation is likely to be effective in such cases.
Unable to tolerate general anesthesia and prone position.
Unable to undergo MRI scan of the spine.
Inability to lie flat on a treatment table for \>60 minutes.
Pregnant. (Urine testing must be done no more than 10 days prior to surgery.)
Prior conventional irradiation of the spine site and level to be treated with an interval shorter than 3 months.
Frank cord compression or cord compression from bone components or configuration and acute neurological deficits (defined as motor strength \<4/5 in extremity or extremities affected by the level of the spinal cord compression)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Detroit?

Yes, this clinical trial (NCT05023772) has an active research site in Detroit, MI that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Neoplasm Metastasis Treatment Options in Detroit, MI

If you're searching for neoplasm metastasis treatment options in Detroit, MI, this clinical trial (NCT05023772) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Detroit research site is actively enrolling participants for this clinical trial. You'll receive care from experienced neoplasm metastasis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all neoplasm metastasis clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Detroit, MI

See all essential tremor clinical trials recruiting in Detroit — not just this study.

Browse Essential Tremor Trials in Detroit →

Browse More Trials by Condition

Essential Tremor TrialsAnkylosing Spondylitis TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Detroit?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Detroit, MI